Table 3.

Mean RVIP task-related contrast estimates post-treatment from the five regions of interest for each treatment group, adjusted for baseline, in both fatigued (n = 16) and non-fatigued cohorts (n = 16).

	ROI	Treatment	M (adj)	SE	F	p	ηp2
Fatigued	Left Parietal	Plac	1.06	0.23	7.95	0.015 ∗	0.379
		MVM	1.96	0.23
	Right Parietal	Plac	1.25	0.21	4.84	0.047 ∗	0.271
		MVM	1.89	0.21
	Left Frontal	Plac	2.08	0.54	2.17	0.164
		MVM	3.21	0.54
	Supplementary Motor Area	Plac	1.40	0.29	7.35	0.018 ∗	0.361
		MVM	2.50	0.29
	Left Insula	Plac	1.32	0.32	0.39	0.543
		MVM	1.62	0.32
Non-fatigued	Left Parietal	Plac	1.88	0.30	0.10	0.760
		MVM	1.75	0.30
	Right Parietal	Plac	1.69	0.26	0.13	0.726
		MVM	1.56	0.26
	Left Frontal	Plac	2.90	0.52	0.06	0.808
		MVM	2.72	0.52
	Supplementary Motor Area	Plac	2.39	0.44	1.22	0.290
		MVM	1.70	0.44
	Left Insula	Plac	1.63	0.40	0.21	0.655
		MVM	1.37	0.40

ROI, region of interest; M (adj), baseline adjusted estimated marginal means;Plac, placebo group; MVM, multi-vitamin and mineral group; ANCOVA results reported for main effect of treatment group; ^∗significant after FDR thresholding.